Hormone Replacement Therapy May Improve Survival for Women with Ovarian Cancer

The randomized, controlled Adjuvant Hormone Therapy trial was launched in 1990 to assess the effects of estrogen-alone hormone replacement therapy in women treated for epithelial ovarian cancer.

Media Type: Html
  • SourceUrl: https://www.cancer.gov/node/1014731/syndication
  • Syndication ID: 3669
  • Language: English
  • Source: National Cancer Institute (NCI)
  • Date Syndication Captured: Friday, October 23, 2015 at 01:00 AM
  • Date Syndication Updated: Monday, August 05, 2019 at 07:39 PM


General: HRT hormone therapy estrogen ovarian cancer hormone replacement therapy postmenopausal symptoms survival institute for cancer research adjuvant therapy women’s health initiative womens health initiative

Preview   0 Users liked this content.

Embed Code Snippet

To get the embed code snippet please Login.